Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Insights and Forecast to 2026

Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Product Introduction
1.2 Market Segments
1.3 Key Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Growth Rate by Type
1.4.2 AMG-228
1.4.3 BMS-986156
1.4.4 FPA-154
1.4.5 GWN-323
1.4.6 INCAGN-1876
1.4.7 Others
1.5 Market by Application
1.5.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Growth Rate by Application
1.5.2 Melanoma
1.5.3 Non-Small Cell Lung Cancer
1.5.4 Gastric Cancer
1.5.5 Blood Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, Estimates and Forecasts
2.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue 2015-2026
2.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales 2015-2026
2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Competitor Landscape by Players
3.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Manufacturers
3.1.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Manufacturers (2015-2020)
3.1.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Manufacturers (2015-2020)
3.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Manufacturers
3.2.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Manufacturers (2015-2020)
3.2.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue in 2019
3.2.5 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Manufacturers
3.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Base Distribution, Product Types
3.4.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Product Type
3.4.3 Date of International Manufacturers Enter into Tumor Necrosis Factor Receptor Superfamily Member 18 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Type (2015-2020)
4.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2015-2020)
4.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Type (2015-2020)
4.1.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast by Type (2021-2026)
4.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Type (2021-2026)
4.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Type (2021-2026)
4.2.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Application (2015-2020)
5.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2015-2020)
5.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Application (2015-2020)
5.1.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Application (2015-2020)
5.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast by Application (2021-2026)
5.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Application (2021-2026)
5.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Application (2021-2026)
5.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Tumor Necrosis Factor Receptor Superfamily Member 18 by Country
6.1.1 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country
6.1.2 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Type
6.3 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Application
7 Europe
7.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 by Country
7.1.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country
7.1.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Type
7.3 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 by Region
8.1.1 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region
8.1.2 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Type
8.3 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 by Country
9.1.1 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country
9.1.2 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Type
9.3 Central & South America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 by Country
10.1.1 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country
10.1.2 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Type
10.3 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Application
11 Company Profiles
11.1 Ablynx NV
11.1.1 Ablynx NV Corporation Information
11.1.2 Ablynx NV Description and Business Overview
11.1.3 Ablynx NV Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
11.1.5 Ablynx NV Related Developments
11.2 Amgen Inc
11.2.1 Amgen Inc Corporation Information
11.2.2 Amgen Inc Description and Business Overview
11.2.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
11.2.5 Amgen Inc Related Developments
11.3 Apogenix GmbH
11.3.1 Apogenix GmbH Corporation Information
11.3.2 Apogenix GmbH Description and Business Overview
11.3.3 Apogenix GmbH Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
11.3.5 Apogenix GmbH Related Developments
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Corporation Information
11.4.2 Bristol-Myers Squibb Company Description and Business Overview
11.4.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
11.4.5 Bristol-Myers Squibb Company Related Developments
11.5 Five Prime Therapeutics Inc
11.5.1 Five Prime Therapeutics Inc Corporation Information
11.5.2 Five Prime Therapeutics Inc Description and Business Overview
11.5.3 Five Prime Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
11.5.5 Five Prime Therapeutics Inc Related Developments
11.6 Incyte Corp
11.6.1 Incyte Corp Corporation Information
11.6.2 Incyte Corp Description and Business Overview
11.6.3 Incyte Corp Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
11.6.5 Incyte Corp Related Developments
11.7 MedImmune LLC
11.7.1 MedImmune LLC Corporation Information
11.7.2 MedImmune LLC Description and Business Overview
11.7.3 MedImmune LLC Sales, Revenue and Gross Margin (2015-2020)
11.7.4 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
11.7.5 MedImmune LLC Related Developments
11.8 Merck & Co Inc
11.8.1 Merck & Co Inc Corporation Information
11.8.2 Merck & Co Inc Description and Business Overview
11.8.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
11.8.5 Merck & Co Inc Related Developments
11.9 Novartis AG
11.9.1 Novartis AG Corporation Information
11.9.2 Novartis AG Description and Business Overview
11.9.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
11.9.5 Novartis AG Related Developments
11.10 OncoMed Pharmaceuticals Inc
11.10.1 OncoMed Pharmaceuticals Inc Corporation Information
11.10.2 OncoMed Pharmaceuticals Inc Description and Business Overview
11.10.3 OncoMed Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
11.10.5 OncoMed Pharmaceuticals Inc Related Developments
11.1 Ablynx NV
11.1.1 Ablynx NV Corporation Information
11.1.2 Ablynx NV Description and Business Overview
11.1.3 Ablynx NV Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered
11.1.5 Ablynx NV Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Estimates and Projections by Region
12.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Regions 2021-2026
12.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Regions 2021-2026
12.2 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast (2021-2026)
12.2.1 North America: Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast (2021-2026)
12.2.2 North America: Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast (2021-2026)
12.2.3 North America: Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast by Country (2021-2026)
12.3 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast (2021-2026)
12.3.1 Europe: Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast (2021-2026)
12.3.2 Europe: Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast (2021-2026)
12.3.3 Europe: Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast by Region (2021-2026)
12.5 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast (2021-2026)
12.5.1 Latin America: Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast (2021-2026)
12.5.2 Latin America: Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast (2021-2026)
12.5.3 Latin America: Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Tumor Necrosis Factor Receptor Superfamily Member 18 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Segments
Table 2. Ranking of Global Top Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AMG-228
Table 5. Major Manufacturers of BMS-986156
Table 6. Major Manufacturers of FPA-154
Table 7. Major Manufacturers of GWN-323
Table 8. Major Manufacturers of INCAGN-1876
Table 9. Major Manufacturers of Others
Table 10. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Regions (2015-2020)
Table 14. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Manufacturers (2015-2020)
Table 17. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Tumor Necrosis Factor Receptor Superfamily Member 18 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 18 as of 2019)
Table 19. Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Price (2015-2020) (USD/Pcs)
Table 22. Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Product Type
Table 24. Date of International Manufacturers Enter into Tumor Necrosis Factor Receptor Superfamily Member 18 Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2015-2020) (K Pcs)
Table 27. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Type (2015-2020)
Table 28. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Type (2015-2020)
Table 30. Tumor Necrosis Factor Receptor Superfamily Member 18 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2015-2020) (K Pcs)
Table 32. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Application (2015-2020)
Table 33. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2015-2020) (K Pcs)
Table 34. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2015-2020)
Table 35. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2015-2020)
Table 37. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2015-2020) (K Pcs)
Table 38. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
Table 39. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2015-2020) (K Pcs)
Table 40. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
Table 41. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2015-2020)
Table 43. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2015-2020)
Table 45. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
Table 47. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
Table 57. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2015-2020)
Table 61. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
Table 63. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
Table 73. Ablynx NV Corporation Information
Table 74. Ablynx NV Description and Major Businesses
Table 75. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Ablynx NV Product
Table 77. Ablynx NV Recent Development
Table 78. Amgen Inc Corporation Information
Table 79. Amgen Inc Description and Major Businesses
Table 80. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Amgen Inc Product
Table 82. Amgen Inc Recent Development
Table 83. Apogenix GmbH Corporation Information
Table 84. Apogenix GmbH Description and Major Businesses
Table 85. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Apogenix GmbH Product
Table 87. Apogenix GmbH Recent Development
Table 88. Bristol-Myers Squibb Company Corporation Information
Table 89. Bristol-Myers Squibb Company Description and Major Businesses
Table 90. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Bristol-Myers Squibb Company Product
Table 92. Bristol-Myers Squibb Company Recent Development
Table 93. Five Prime Therapeutics Inc Corporation Information
Table 94. Five Prime Therapeutics Inc Description and Major Businesses
Table 95. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Five Prime Therapeutics Inc Product
Table 97. Five Prime Therapeutics Inc Recent Development
Table 98. Incyte Corp Corporation Information
Table 99. Incyte Corp Description and Major Businesses
Table 100. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Incyte Corp Product
Table 102. Incyte Corp Recent Development
Table 103. MedImmune LLC Corporation Information
Table 104. MedImmune LLC Description and Major Businesses
Table 105. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. MedImmune LLC Product
Table 107. MedImmune LLC Recent Development
Table 108. Merck & Co Inc Corporation Information
Table 109. Merck & Co Inc Description and Major Businesses
Table 110. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Merck & Co Inc Product
Table 112. Merck & Co Inc Recent Development
Table 113. Novartis AG Corporation Information
Table 114. Novartis AG Description and Major Businesses
Table 115. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Novartis AG Product
Table 117. Novartis AG Recent Development
Table 118. OncoMed Pharmaceuticals Inc Corporation Information
Table 119. OncoMed Pharmaceuticals Inc Description and Major Businesses
Table 120. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. OncoMed Pharmaceuticals Inc Product
Table 122. OncoMed Pharmaceuticals Inc Recent Development
Table 123. Regeneron Pharmaceuticals Inc Corporation Information
Table 124. Regeneron Pharmaceuticals Inc Description and Major Businesses
Table 125. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Regeneron Pharmaceuticals Inc Product
Table 127. Regeneron Pharmaceuticals Inc Recent Development
Table 128. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 129. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share Forecast by Regions (2021-2026)
Table 130. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 131. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share Forecast by Regions (2021-2026)
Table 132. North America: Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Country (2021-2026) (K Pcs)
Table 133. North America: Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Europe: Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Country (2021-2026) (K Pcs)
Table 135. Europe: Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Asia Pacific: Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Region (2021-2026) (K Pcs)
Table 137. Asia Pacific: Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 138. Latin America: Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Country (2021-2026) (K Pcs)
Table 139. Latin America: Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Middle East and Africa: Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Country (2021-2026) (K Pcs)
Table 141. Middle East and Africa: Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 143. Key Challenges
Table 144. Market Risks
Table 145. Main Points Interviewed from Key Tumor Necrosis Factor Receptor Superfamily Member 18 Players
Table 146. Tumor Necrosis Factor Receptor Superfamily Member 18 Customers List
Table 147. Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Tumor Necrosis Factor Receptor Superfamily Member 18 Product Picture
Figure 2. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type in 2020 & 2026
Figure 3. AMG-228 Product Picture
Figure 4. BMS-986156 Product Picture
Figure 5. FPA-154 Product Picture
Figure 6. GWN-323 Product Picture
Figure 7. INCAGN-1876 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application in 2020 & 2026
Figure 10. Melanoma
Figure 11. Non-Small Cell Lung Cancer
Figure 12. Gastric Cancer
Figure 13. Blood Cancer
Figure 14. Others
Figure 15. Tumor Necrosis Factor Receptor Superfamily Member 18 Report Years Considered
Figure 16. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size 2015-2026 (US$ Million)
Figure 17. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales 2015-2026 (K Pcs)
Figure 18. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region (2015-2020)
Figure 20. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region in 2019
Figure 21. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Region (2015-2020)
Figure 22. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Region in 2019
Figure 23. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue in 2019
Figure 25. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2015-2020)
Figure 27. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type in 2019
Figure 28. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Type (2015-2020)
Figure 29. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Type in 2019
Figure 30. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Price Range (2015-2020)
Figure 31. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2015-2020)
Figure 32. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application in 2019
Figure 33. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Application (2015-2020)
Figure 34. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Application in 2019
Figure 35. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country in 2019
Figure 38. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country in 2019
Figure 39. U.S. Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Growth Rate (2015-2020

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs